Save Product
Product Details
Product Specifications
Assay TypeIndirect-ELISAAnalyteDLL4Format96T (8×12 strips)ReactivityHumanRegulatory StatusRUOSensitivity< 7.81pg/mLStandard Curve Range7.81 pg/mL-500 pg/mLAssay Time2 hr 20 minSuitable Sample TypeFor the quantitative determination of human DLL4 in Cell Culture Supernatants, Plasma, Serum.Sample volume100 μLProduct Overview
Biotinylated Human DLL4 ELISA Kit (Residue Testing) is based on the ELISA indirect method and is used to detect and quantitatively determine GMP biotinylated human DLL4 residues in cell culture supernatants, serum, and plasma. The kit contains GMP biotinylated human DLL4 (ACROBiosystems, cat# GMP-DL4H23) to ensure accurate assay results and is designed to provide a reliable solution for CAR-T product quality assessment during drug development and CMC quality control stages. It can also be used as a universal detection tool for the quantitative determination of biotinylated human DLL4.
Reconstitution
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
Storage
1. Unopened kit should be stored at 2℃-8℃ upon receiving.
2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Materials Provided
IDComponentsSizeRES022-C01Pre-coated Anti-DLL4 Antibody Microplate1 plate (8×12 strips)RES022-C02Biotinylated Human DLL4 Standard20 μgRES022-C03Streptavidin-HRP50 μLRES022-C0410xWashing Buffer50 mLRES022-C052xDilution Buffer50 mLRES022-C06Substrate Solution12 mLRES022-C07Stop Solution7 mLACRO Quality Management System
Customers Also Viewed
Performance Data
Typical Data
Please refer to DS document for the assay protocol.
For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.
Customer Reviews Writing Reviews
Recent Advances
Drug Development Progress- English Name：
Delta-like protein 4
- Category：
- Approved Drugs：
0 Details
- Drugs in Clinical Trials：
3 Details
- Highest Development Stage：
Phase 3 Clinical
Contact Us
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
Drug Candidate Licensing
